References
- Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.31937
- Fan L, Strasser-Weippl K, Jun-Jie L, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–89. doi:10.1016/S1470-2045(13)70567-9
- Muller HM, Widschwendter A, Fiegl H, et al. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res. 2003;63:7641–7645.
- Cheuk IW, Shin VY, Kwong A. Detection of methylated circulating DNA as noninvasive biomarkers for breast cancer diagnosis. J Breast Cancer. 2017;20(1):12–19. doi:10.4048/jbc.2017.20.1.12
- Feinberg AP, Koldobskiy MA, Göndör A. Epigenetic modulators, modifers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17:284–299. doi:10.1038/nrg.2016.13
- Lu DG, Ma YM, Zhu AJ, Han YW. An early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysis. Oncotarget. 2016;8(13):22166–22174. doi:10.18632/oncotarget.13125
- Heng J, Guo X, Wenhan W, et al. Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients. PLoS One. 2017;12(3):e0174022. doi:10.1371/journal.pone.0174022
- Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B. Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenetics. 2016;8:115. doi:10.1186/s13148-016-0282-6
- Yadav P, Masroor M, Nandi K, Kaza RCM, Jain SK, Khurana N, Saxena A. Promoter methylation of BRCA1, DAPK1 and RASSF1A is associated with increased mortality among Indian women with breast cancer. APJCP. 2017;19(2):443–448.
- Hill VK, Ricketts C, Bieche I, et al. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res. 2011;71(8):2988–2999. doi:10.1158/0008-5472.CAN-10-4026
- Li Z, Guo X, Wu Y, et al. Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients. Breast Cancer Res Treat. 2015;149(3):767–779. doi:10.1007/s10549-015-3276-8
- Stirzaker C, Zotenko E, Song JZ, et al. Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value. Nat Commun. 2015;6:5899. doi:10.1038/ncomms6899
- Lau QC, Raja E, Salto-Tellez M, et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res. 2006;66(13):6512–6520. doi:10.1158/0008-5472.CAN-06-0369
- Shan M, Yin HZ, Li J, et al. Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer. Oncotarget. 2016;7(14):18485–18494. doi:10.18632/oncotarget.7608